Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,068,125 | 0 | 209,775 | 262,022 | 72.85% | +52,247 |
| Verona Pharma plc (VRNA) | 615,352 | 615,352 | 0 | 39,069 | 58,200 | 16.18% | +19,131 |
| Biomea Fusion Inc (BMEA) | 798,757 | 2,048,757 | +1,250,000 | 1,701 | 3,688 | 1.03% | +1,986 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,541,009 | 0 | 4,472 | 4,955 | 1.38% | +483 |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | 735 | 1,041 | 0.29% | +306 |
| Marker Therapeutics, Inc. (MRKR) | 325,370 | 325,370 | 0 | 400 | 498 | 0.14% | +98 |
| Aclaris Therapeutics Inc (ACRS) | 434,455 | 434,455 | 0 | 665 | 617 | 0.17% | -48 |
| Compass Pathways Plc (CMPS)(CMPS) | 1,198,418 | 1,198,418 | 0 | 3,427 | 3,356 | 0.93% | -72 |
| CalciMedica, Inc. (CALC) | 521,114 | 521,114 | 0 | 995 | 834 | 0.23% | -162 |
| OnKure Therapeutics, Inc. (OKUR) | 88,607 | 88,607 | 0 | 381 | 212 | 0.06% | -169 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 6,832 | 6,640 | 1.85% | -191 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,025,000 | 1,316,806 | +291,806 | 12,587 | 12,325 | 3.43% | -262 |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | 7,413 | 5,285 | 1.47% | -2,128 |